Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U8335AA | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2117047 | OT |
no adverse event; improperly stored; This spontaneous report was received from an Other health professional and refers to a 2-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-Oct-2025, the patient started therapy with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), Oral solution (lot #2117047, expiration date: 18-May-2026) 2 mL administered by Oral route. On 21-Oct-2025, the patient started therapy with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus, (VAXELIS), (lot #U8335AA, expiration date: 31-Oct-2027) 0.5 mL. The vaccines were improperly stored. The patient experienced no adverse event.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-12-16 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : , Central date : 2025-12-11 , Classification : , Attachment description : Minimal Data Entry , Safety case number :